These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 729293)

  • 21. In vitro drug sensitivity of M. avium-intracellulare complex in the presence and absence of dimethyl sulphoxide.
    Nash DR; Steingrube VA
    Microbios; 1982; 35(140):71-8. PubMed ID: 7162431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quality control of culture media for mycobacterium drug sensitivity tests].
    Kekkaku; 2003 Aug; 78(8):563-8. PubMed ID: 14582504
    [No Abstract]   [Full Text] [Related]  

  • 23. [Rapid visual test for the determination of drug resistance in comparison with the economic test].
    Reutgen H; Kalich R
    Z Erkr Atmungsorgane; 1974; 140(3):255-63. PubMed ID: 4499423
    [No Abstract]   [Full Text] [Related]  

  • 24. Disseminated infection due to multidrug-resistant Mycobacterium bovis in a patient who was seropositive for human immunodeficiency virus.
    Schultsz C; Kuijper EJ; van Soolingen D; Prins JM
    Clin Infect Dis; 1996 Oct; 23(4):841-3. PubMed ID: 8909864
    [No Abstract]   [Full Text] [Related]  

  • 25. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study of 2d order tuberculostatic preparations in Mycobacterium bovis resistance to isoniazid or streptomycin (based on the data from a morphological study)].
    Golyshevskaia VI; El'shanskaia MP
    Farmakol Toksikol; 1975; 38(2):222-4. PubMed ID: 776650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
    Echeverría MJ; Ayarza R; Jiménez MS; López de Goicoechea MJ; Berdonces P; Ibarretxebea AB
    Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678
    [No Abstract]   [Full Text] [Related]  

  • 28. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
    Janowiec M; Zwolska-Kwiek Z
    Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
    [No Abstract]   [Full Text] [Related]  

  • 29. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
    Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
    J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale for chemotherapy of tuberculosis and current recommendations.
    Kumar L
    Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug therapy of tuberculosis. Advanced training and working conference at the Central Hospital Gauting of the State Insurance Company of Upper Bavaria on Nov. 9, 1968].
    Erhard G
    Med Klin; 1969; 64(26):1215-7. PubMed ID: 4979959
    [No Abstract]   [Full Text] [Related]  

  • 34. Pacemaker wire infection with Mycobacterium tuberculosis: a case report and literature review.
    Kestler M; Reves R; Belknap R
    Int J Tuberc Lung Dis; 2009 Feb; 13(2):272-4. PubMed ID: 19146760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Jul; 41(28):507-9. PubMed ID: 1630427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
    Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T; Motomura K
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract]   [Full Text] [Related]  

  • 38. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 39. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay.
    Yang Z; Durmaz R; Yang D; Gunal S; Zhang L; Foxman B; Sanic A; Marrs CF
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):201-8. PubMed ID: 16243477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Statement on tuberculosis treatment].
    Rasmussen KN
    Ugeskr Laeger; 1973 Aug; 135(34):1829-30. PubMed ID: 4781310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.